Home Insemination Market - Forecast(2024 - 2030)

Report Code: HCR 0592 Report Format: PDF + Excel

Home Insemination Market Overview

The Home Insemination Market size is forecast to reach $171.82 million by 2026, growing at a CAGR of 3.7% during the period 2021-2026. Home insemination is an artificial form of insemination to deliver sperm on the uterus within the hopes of getting pregnant. Lower cost in comparison to other fertilization procedures and growing cases of male & female infertility is the major factor driving the growth of the market. Favourable governmental laws in developed countries for fertility procedure is set to further enhance the overall market demand for the Home Insemination Market for the period 2021-2026.

Report Coverage

The report: “Home Insemination Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Home Insemination Market.
By Product: Home Conception Devices, Insemination Kits, and Accessories.
By Type: Turkey Baster Method (Intracervical Insemination), and Intrauterine Insemination.
By Geography: North America, Europe, Asia Pacific (APAC), and Rest of the World (RoW).

Key Takeaways

  • North America dominated the Home Insemination Market in 2020 owing to the increased demand for home insemination by single mothers & lesbian couples, and the increasing prevalence of infertility among adults. The Home Insemination Market scope for different regions will be provided in the final report.
  • Growing awareness about single parenthood and same-sex parenthood and well-developed healthcare infrastructure is likely to aid in the market growth of the Home Insemination Market.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Home Insemination Market report.
  • Stringent government laws on fertility in some developing countries and safety issue is poised to create hurdles for the Home Insemination Market.

Home Insemination Market Segment Analysis - By Product

The Insemination Kits held the largest share in the Home Insemination Market in 2020 and is estimated to grow at a CAGR of 4.0% during the forecast period 2021-2026. Increasing adoption of these kits among women from developed countries and new product launches have driven the growth of this segment. Home insemination kits are prescribed to the couples experiencing unexplained infertility, difficulty with intercourse, conceivably ordinary sperm production, abnormal seminal liquid, and ovulatory problem receptive to fertility medication. The Insemination Kits are set to be the highest growing segment and are estimated to register the highest CAGR during the aforesaid period.

Home Insemination Market Segment Analysis - By Type

Intrauterine Insemination held the largest share in the Home Insemination Market in 2020. Intrauterine Insemination is a treatment during which sperm is placed inside a uterus to facilitate fertilization. It increases the number of sperm that reaching the fallopian tubes, thus increasing the chance of fertilization. Intrauterine insemination is not for those women who have diseases of the fallopian tubes or have a history of pelvic infections. Intracervical Insemination is set to be the highest growing segment and is estimated to register the highest CAGR during the period 2021-2026.

Home Insemination Market Segment Analysis - By Geography

North America dominated the Home Insemination Market in 2020 with a share of more than 41.02%. This is owing to the growing demand for Home Insemination by single mothers & lesbian couples and increasing prevalence of infertility among adults. Technological advancements, favourable rules, and regulations, increasing health sector and private sector investments are factors increasing the growth of the Home Insemination Market in North America.

However, Asia Pacific is estimated to grow at a higher CAGR during the period 2021-2026 owing to changing social structures, entry of new market players in the region, and increasing disposable income of the population.

Home Insemination Market Drivers

Increasing Prevalence of Infertility

The increasing prevalence of infertility is increasing the growth of the Home Insemination Market. Infertility helps patients to conceive who are not able to conceive normally. Infertility can occur in either of the couples and in some cases, the problem can be there in both. It is very different from the natural and conventional methods of conception. Here the eggs and sperms are combined outside in a laboratory to make the embryos and are later placed in the uterus. Initially, the sector of reproductive medicine is initiated to assist infertile couples, but with a far better understanding of the method, it can now be extended to several others who desire help. Thus, increasing the growth of the Home Insemination Market during the period 2021-2026.

Increasing Advancements in Technology of Fertility Treatment

Increasing advancements in the technology of fertility treatment are increasing the growth of the Home Insemination Market. Infertility is especially owing to a special gynaecological disorder like ovulation disorder, fallopian tube damage, hormonal problems, cervical issues, and polycystic ovary syndrome including many health issues which is set to infertility. A new technique of fertilizing the egg of two women in a single sperm is by creating three parent embryos. In this technique, part of the eggs from two women is taken and fertilized in a man’s sperm. Young men and ladies can freeze their eggs and sperms for later use. Thus, increasing the growth of the Home Insemination Market during the forecast period 2021-2026.

Home Insemination Market Challenges

Stringent Government Laws on Fertility in Some Developing Countries and Safety Issue 

Some of the factors that are set to impede the growth of the Home Insemination Market is the stringent government laws on fertility in some developing countries and safety issues. High risk of transmission of sexually transmitted disease, issue of multiple births and there is a chance of a woman giving birth to twins or triplets is hampering the growth of the Home Insemination Market over the period 2021-2026.

Home Insemination Market Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Home Insemination Market. In 2020, the Home Insemination Market share is consolidated by the top ten players present in the market which are Rinovum Women’s Health, LLC, Pride Angel, Hi-Tech Solutions, Kitazato Corp., Rocket Medical plc., Conception Kit Company, Conceivex, Inc., Labotech GmbH, Hamilton Thorn Ltd. and Zander scientific Inc. among others.

Acquisitions/Product Launches

  • In August 2019, Hamilton Throne acquired Planer Limited to develop research. This acquisition enhances the products offerings in incubation, cryopreservation and lab monitoring solutions and working to reduce cost, increase productivity, improve results
  • In September 2020, MedGyn has acquired Thomas Medical. This will allow MedGyn to focus on domestic manufacturing and distribution globally while providing customers access to Thomas Medical’s product portfolio.

For more Lifesciences and Healthcare Market reports - Please Click Here
1. Home Insemination Market - Overview
    1.1 Definitions and Scope
2. Home Insemination Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product 
    2.3 Key trends by Type
    2.4 Key trends by Geography
3. Home Insemination Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Home Insemination Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Home Insemination Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Home Insemination Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Home Insemination Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Home Insemination Market – By Product (Market Size – $Million/$Billion)
    8.1 Home Conception Devices
    8.2 Insemination Kits
    8.3 Accessories
9. Home Insemination Market – By Type(Market Size – $Million/$Billion)
    9.1 Turkey Baster Method(Intracervical Insemination)
    9.2 Intrauterine Insemination
10. Home Insemination Market - By Geography(Market Size – $Million/$Billion) 
    10.1 North America
        10.1.1 U.S.
        10.1.2 Mexico
        10.1.3 Canada
    10.2 Europe
        10.2.1 U.K.
        10.2.2 France
        10.2.3 Germany
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Rest of Europe
    10.3 Asia Pacific
        10.3.1 China
        10.3.2 India
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 Australia & New Zealand
        10.3.6 Rest of APAC
    10.4 Rest of the World
        10.4.1 Middle East
        10.4.2 Africa
        10.4.3 South America
11. Home Insemination Market - Entropy
12. Home Insemination Market – Industry/Segment Competition Landscape Premium 
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key companies
        12.1.3 Market Share by Countries – Key Companies
        12.1.4 Best Practices for Companies
13. Home Insemination Market – Key Company List by Country Premium Premium
14. Home Insemination Market Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.